COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,385 Articles (22,816 medRxiv, 8,569 bioRxiv)

Most recent first Previous |  Page 379: Articles 3781-3790  | Next

A Susceptible Vaccinated Exposed Infected Hospitalised and Removed/Recovered (SVEIHR) Model Framework for COVID-19
Oyamakin, O. S., Popoola, J. I.
10.1101/2023.08.10.23293942 — Posted: 2023-08-15
Effect of vaccination certification with mass vaccination and non-pharmaceutical interventions on mitigating COVID-19
Cao, H., Cao, L.
10.1101/2023.08.10.23293925 — Posted: 2023-08-15
Digital Mental Health Service engagement changes during Covid-19 in children and young people across the UK: presenting concerns, service activity, and access by gender, ethnicity, and deprivation
Knipe, D., de Ossorno Garcia, S., Salhi, L., Mainstone-Cotton, L., Sefi, A., John, A.
10.1101/2023.08.11.23293977 — Posted: 2023-08-15
A Scoping Review of Pacing for Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Lessons Learned for the Long COVID Pandemic
Sanal-Hayes, N., Mclaughlin, M., Hayes, L. D. D., Mair, J., Ormerod, J., Carless, D., Hilliard, N., Meach, R., Ingram, J., Sculthorpe, N.
10.1101/2023.08.10.23293935 — Posted: 2023-08-15
Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study
Pearson, L., Maina, A., Thompson, L., Harden, S., Aaroe, A., Compratt, T.
10.1101/2023.08.10.23290338 — Posted: 2023-08-15
SARS-CoV-2 infection triggers pro-atherogenic inflammatory 1 responses in human coronary vessels
Eberhardt, N., Noval, M. G., Kaur, R., Sajja, S., Amadori, L., Das, D., Cilhoroz, B., Stewart, O. J., Fernandez, D. M., Shamailova, R., Guillen, A. V., Jangra, S., Schotsaert, M., Gildea, M., Newman, J. D., Faries, P., Maldonado, T., Rockman, C., Rapkiewicz, A., Stapleford, K. A., Narula, N., Moore, K. J., Giannarelli, C.
10.1101/2023.08.14.553245 — Posted: 2023-08-15
SARS-CoV-2 Neutralizing Antibodies Following a Second BA.5 Bivalent Booster
Wang, Q., Bowen, A., Ho, J., Zhang, R., Valdez, R., Stoneman, E., Gordon, A., Lihong, L., Ho, D. D.
10.1101/2023.08.13.553148 — Posted: 2023-08-14
Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model
D Krishna, V., Chang, A., Korthas, H., Var, S. R., Low, W. C., Li, L., Cheeran, M. C.-J.
10.1101/2023.08.11.552998 — Posted: 2023-08-14
Met58 and di-acidic motif located at C-terminal region of SARS-CoV-2 ORF6 plays a crucial role in its structural conformations
Kumar, P., Saumya, K. U., Bhardwaj, T., Giri, R.
10.1101/2023.08.14.553212 — Posted: 2023-08-14
Pandemic preparedness through genomic surveillance: Overview of mutations in SARS-CoV-2 over the course of COVID-19 outbreak
Najar, F. Z., Murphy, C. L., Linde, E., Borin, V. A., Wang, H., Haider, S., Agarwal, P. K.
10.1101/2023.08.12.553079 — Posted: 2023-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).